UK clinical trials - updated daily from ClinicalTrials.gov
Find clinical trials for blood cancers (leukaemia, lymphoma, myeloma) in the United Kingdom. Explore treatment pathways for haematological malignancies.
Blood cancers affect ~40,000 people per year in the UK. The three main groups are lymphomas (cancer of lymphocytes), leukaemias (cancer of blood cells in bone marrow), and myeloma (cancer of plasma cells). Treatment has been revolutionised by targeted therapies, immunotherapy, and cellular therapies like CAR-T.
CAR-T therapy modifies your own T-cells to recognise and attack cancer cells. Available on the NHS for: relapsed diffuse large B-cell lymphoma (axicabtagene, tisagenlecleucel), relapsed B-cell ALL (tisagenlecleucel), and relapsed myeloma (ciltacabtagene). This is one of the most exciting advances in cancer treatment.
The UK has a strong blood cancer research infrastructure through Blood Cancer UK and the NHS. Active trial areas: next-generation CAR-T, bispecific antibodies (glofitamab, epcoritamab), new targeted drugs (venetoclax combinations), and combination immunotherapy. Many trials are available at major haematology centres nationwide.
Free AI-powered matching - no signup required
Search leukaemia Trials →